J0642 Levoleucovorin - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Levoleucovorin

Brand Name:

Khapzory

Strength:

0.5mg

HCPCS:

J0642

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Chemoprotective

Minor Drug Class:

Antidote

Oral (Y/N):

No

FDA Approval Year:

2018

FDA Discontinuation Year:

CMS Effective Date:

Oct. 1, 2019

CMS Discontinuation Date:

Status:

In Use